Alefacept Mechanism of Action in Psoriasis

NCT00150982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Mechanism of action of alefacept

Sponsor

University of Medicine and Dentistry of New Jersey

Collaborators

[object Object]